Position in QDEL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,166,016
+$1,955,812 QoQ
Shares Held
131,833
+2093.2% QoQ
Ownership
0.193%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
9 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in QDEL Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026MARSHALL WACE, LLP holds $1,200,961,606 across 58 Medical Devices names. QDEL ranks #30 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
3,611,020 | $226,591,504 | |
| 2 | SYK |
Stryker Corp
|
630,236 | $207,089,246 | |
| 3 | ABT |
Abbott Laboratories
|
2,010,938 | $206,463,003 | |
| 4 | EW |
Edwards Lifesciences Corp
|
1,996,377 | $159,869,868 | |
| 5 | PODD |
Insulet Corp
|
606,482 | $127,264,182 | |
| 6 | GMED |
Globus Medical Inc
|
562,630 | $48,476,200 | |
| 7 | TNDM |
Tandem Diabetes Care Inc
|
1,442,472 | $27,652,186 | |
| 8 | HAE |
Haemonetics Corp
|
320,010 | $18,035,762 |
All Filings in QDEL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,166,016 | 131,833 | Shares | Other | 2026-05-15 | |
| 2025-03-31 | $210,204 | 6,011 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $10,705,007 | 240,292 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $482,676 | 10,585 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $4,769,893 | 143,585 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $2,101,210 | 43,830 | Shares | Other | 2024-05-15 | |
| 2023-06-30 | $1,584,531 | 19,123 | Shares | Other | 2023-08-14 | |
| 2022-12-31 | $282,711 | 3,300 | Shares | Other | 2023-02-14 | |
| 2022-06-30 | $243,435 | 2,505 | Shares | Other | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||